David Jin - Dec 20, 2023 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Role
Chief Financial Officer
Signature
/s/ David Jin
Stock symbol
FBIO
Transactions as of
Dec 20, 2023
Transactions value $
$0
Form type
4
Date filed
12/22/2023, 04:05 PM
Previous filing
Jul 5, 2023
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBIO COMMON STOCK, PAR VALUE $0.001 Award $0 +140K +145.96% $0.00 236K Dec 20, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split.
F2 Represents an award of 140,000 restricted stock units which will vest in 16 equal quarterly installments after the grant date, December 20, 2023. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and the consummation of a Corporate Transaction (as defined in the Fortress Biotech, Inc. 2013 Stock Incentive Plan); the amount will be distributed in the form of the Issuer's common stock.
F3 Total holdings include 230,000 shares underlying deferred restricted stock units.